封面
市場調查報告書
商品編碼
1654364

全球瓣環成形裝置市場:市場規模、佔有率、趨勢分析(按應用、最終用途和地區)、細分市場預測(2025-2030 年)

Balloon Valvuloplasty Devices Market Size, Share & Trends Analysis Report By Application (Aortic Valve Stenosis, Pulmonary Valve Stenosis), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

瓣環成形設備市場的成長與趨勢:

根據Grand View Research, Inc.的最新報告,全球球囊瓣環成形裝置市場規模預計到2030年將達到30.2億美元,2025年至2030年複合年成長率為4.1%。

心血管疾病(包括心臟瓣膜疾病)盛行率的上升、新產品的推出、監管部門的核准以及先進的醫療保健基礎設施正在推動北美對球囊瓣環成形設備的需求。風濕性心臟疾病(RHD) 是一種因風濕熱引起心臟瓣膜損傷而導致的嚴重心血管疾病。

根據美國心臟協會 2024 年 4 月的報告,心臟瓣膜疾病 (VHD) 是美國最常見的健康狀況之一,影響約 2.5% 的成年人口。主動脈瓣和二尖瓣疾病是最常見的 VHD 類型,進一步凸顯了球囊瓣環成形成形術等有效治療方案對於解決這一日益嚴重的健康問題至關重要。

不斷增強的認知和篩檢計劃正在推動市場成長。例如,2024 年 9 月,全球心臟中心發起了宣傳活動,強調心臟瓣膜疾病的發生率不斷上升,預計到 2040 年發病率將加倍,到 2060 年將翻三倍。這些努力強調了透過定期健康檢查進行早期發現的重要作用。該組織旨在向公眾宣傳這種疾病以及可用的治療方法,例如球囊瓣環成形。

球囊瓣環成形市場:概述

  • 根據應用,主動脈瓣狹窄部分在 2024 年佔據最大佔有率,超過 64.42%。全球範圍內心臟瓣膜疾病盛行率的上升和技術的進步正在推動這一領域的成長。
  • 根據最終用途,醫院部門在 2024 年佔據最大的收益佔有率,為 57.4%。隨著全球心臟瓣膜疾病的發生率不斷上升,醫院需要先進的解決方案來有效管理病患照護。
  • 由於患有心血管疾病(包括心臟瓣膜疾病)的患者數量不斷增加,北美將在 2024 年佔據 41.1% 的佔有率。產品發布、監管部門核准和先進的醫療基礎設施正在推動對球囊瓣環成形設備的需求。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

3.瓣環成形設備市場:促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 瓣環成形裝置市場:分析工具
    • 產業分析:波特五力分析
    • PESTEL 分析

第4章瓣環成形裝置市場:按應用分類的估計和趨勢分析

  • 瓣環成形設備市場:按應用分類的儀表板
  • 瓣環成形裝置市場:應用趨勢分析
  • 瓣環成形裝置市場:按應用分類的市場規模預測和趨勢分析(2018-2030 年)
  • 主動脈瓣狹窄
  • 肺動脈狹窄

第 5 章瓣環成形裝置市場:按最終用途的估計和趨勢分析

  • 瓣環成形設備市場:依最終用途分類的儀表板
  • 瓣環成形裝置市場:依最終用途進行的變化分析
  • 瓣環成形設備市場:按最終用途分類的市場規模預測和趨勢分析(2018-2030 年)
  • 醫院
  • 門診手術中心(ASC)
  • 心導管實驗室

6.瓣環成形裝置市場:區域估計和趨勢分析(按應用和最終用途)

  • 全球瓣環成形設備市場:按地區分類的儀表板
  • 市場規模預測及趨勢分析(2018-2030年)
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要製造商的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商概況
    • 主要經銷商及通路夥伴名單
    • Key customers
    • Key company market share analysis, 2024
    • B. Braun Interventional Systems, Inc.
    • BD
    • Edwards Lifesciences Corporation
    • Boston Scientific Corporation
    • Getinge
    • TORAY INTERNATIONAL AMERICA, INC.
    • Stryker
    • BrosMed Medical Co., Ltd.
    • Medtronic
    • Terumo Corporation
    • Koninklijke Philips NV
Product Code: GVR-4-68040-438-3

Balloon Valvuloplasty Devices Market Growth & Trends:

The global balloon valvuloplasty devices market size is expected to reach USD 3.02 billion by 2030, registering a CAGR of 4.1% from 2025 to 2030, according to a new report by Grand View Research, Inc.The increasing prevalence of cardiovascular diseases, including valvular heart diseases, new product launches, regulatory approvals, and advanced healthcare infrastructure, drives the demand for balloon valvuloplasty devices in North America. Rheumatic heart disease (RHD) is a serious cardiovascular condition that arises from damage to the heart valves due to rheumatic fever.

According to a report published by the American Heart Association in April 2024, valvular heart disease (VHD) is among the most prevalent health conditions in the U.S., affecting about 2.5% of the adult population. Aortic and mitral valve diseases are the most diagnosed types of VHD, further emphasizing the critical need for effective treatment options like balloon valvuloplasty devices to address this growing health concern.

Increasing awareness and screening programs fuel the market's growth. For instance, in September 2024, the Global Heart Hub initiated campaigns highlighting the rising prevalence of heart valve disease, which is expected to double by 2040 and triple by 2060. These efforts stress the critical role of early detection through regular medical check-ups. The organization aims to inform the public about the symptoms and available treatments, such as balloon valvuloplasty.

Balloon Valvuloplasty Devices Market Report Highlights:

  • Based on application, the aortic valve stenosis segment held the largest share, over 64.42%, in 2024. The global rise in the incidence of valvular heart diseases and technological advancements drive the segment's growth
  • Based on end use, the hospital segment held the largest revenue share at 57.4% in 2024. The rising incidence of valvular heart diseases globally necessitates advanced solutions within hospitals to manage patient care effectively
  • North America dominated the market with a share of 41.1% in 2024, owing to the rising cases of cardiovascular diseases, including valvular heart diseases. Product launches, regulatory approvals, and advanced healthcare infrastructure drive the demand for balloon valvuloplasty devices

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application Segment
    • 2.2.2. End use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Balloon Valvuloplasty Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of valvular heart diseases
      • 3.2.1.2. Technological advancements in balloon valvuloplasty devices
      • 3.2.1.3. Increasing awareness and screening programs
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost associated with the devices and procedures
      • 3.2.2.2. Regulatory compliance
  • 3.3. Balloon Valvuloplasty Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Balloon Valvuloplasty Devices Market: Application Estimates & Trend Analysis

  • 4.1. Balloon Valvuloplasty Devices Market: Application Dashboard
  • 4.2. Balloon Valvuloplasty Devices Market: Application Movement Analysis
  • 4.3. Balloon Valvuloplasty Devices Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Aortic Valve Stenosis
    • 4.4.1. Market estimates and forecasts 2018 to 2030, (USD Million)
  • 4.5. Pulmonary Valve Stenosis
    • 4.5.1. Market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 5. Balloon Valvuloplasty Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Balloon Valvuloplasty Devices Market: End Use Dashboard
  • 5.2. Balloon Valvuloplasty Devices Market: End Use Movement Analysis
  • 5.3. Balloon Valvuloplasty Devices Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecasts 2018 to 2030, (USD Million)
  • 5.5. Ambulatory Surgical Centers (ASCs)
    • 5.5.1. Market estimates and forecasts 2018 to 2030, (USD Million)
  • 5.6. Cardiac Catheterization Labs
    • 5.6.1. Market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 6. Balloon Valvuloplasty Devices Market: Regional Estimates & Trend Analysis by Country, Application, & End use

  • 6.1. Global Balloon Valvuloplasty Devices Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030, (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030, (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030, (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030, (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030, (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2024
    • 7.3.4. B. Braun Interventional Systems, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. BD
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Edwards Lifesciences Corporation
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Boston Scientific Corporation
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Getinge
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. TORAY INTERNATIONAL AMERICA, INC.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Stryker
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. BrosMed Medical Co., Ltd.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Medtronic
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Terumo Corporation
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Koninklijke Philips N.V.
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 4. Global balloon valvuloplasty devices market, by end use, 2018 - 2030
  • Table 5. Global balloon valvuloplasty devices market, by region, 2018 - 2030 (USD Million)
  • Table 6. North America balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 8. North America balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 9. U.S. balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 10. U.S. balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 11. Canada balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 12. Canada balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 13. Mexico balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 14. Mexico balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 15. Europe balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 16. Europe balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 17. Europe balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 18. UK balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 19. U.K. balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 20. Germany balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 21. Germany balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 22. France balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 23. France balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 24. Italy balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 25. Italy balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 26. Spain balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 27. Spain balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 28. Denmark balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 29. Denmark balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 30. Sweden balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 31. Sweden balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 32. Norway balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 33. Norway balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 37. Japan balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 38. Japan balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 39. China balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 40. China balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 41. India balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 42. India balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 43. Australia balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 44. Australia balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 45. Australia balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 46. Thailand balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 47. Thailand balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 48. South Korea balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 49. South Korea balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 50. Latin America balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 51. Latin America balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 52. Latin America balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 53. Brazil balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 54. Brazil balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 55. Argentina balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 56. Argentina balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 57. MEA balloon valvuloplasty devices market, by country, 2018 - 2030 (USD Million)
  • Table 58. MEA balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 59. MEA balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 60. South Africa balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 61. South Africa balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 63. Saudi Arabia balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 64. UAE balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 65. UAE balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 66. Kuwait balloon valvuloplasty devices market, by application, 2018 - 2030 (USD Million)
  • Table 67. Kuwait balloon valvuloplasty devices market, by end use, 2018 - 2030 (USD Million)
  • Table 68. Participant's overview
  • Table 69. Financial performance
  • Table 70. Key companies undergoing expansions
  • Table 71. Key companies undergoing acquisitions
  • Table 72. Key companies undergoing collaborations
  • Table 73. Key companies launching new products
  • Table 74. Key companies undergoing partnerships
  • Table 75. Key companies undertaking other strategies

List of Figures

  • Fig. 1 Balloon valvuloplasty devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Balloon valvuloplasty devices market revenues, 2024, (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Balloon valvuloplasty devices market application outlook:
  • Fig. 14 Balloon valvuloplasty devices market: application movement analysis
  • Fig. 15 Global aortic valve stenosis market, 2018 - 2030 (USD Million)
  • Fig. 16 Global pulmonary valve stenosis market, 2018 - 2030 (USD Million)
  • Fig. 17 Balloon valvuloplasty devices market end use outlook:
  • Fig. 18 Balloon valvuloplasty devices market: end use movement analysis
  • Fig. 19 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 20 Global ambulatory surgical centers (ASCs) market, 2018 - 2030 (USD Million)
  • Fig. 21 Global cardiac catheterization labs market, 2018 - 2030 (USD Million)
  • Fig. 22 Regional market place: Key takeaways
  • Fig. 23 North America balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 24 US balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 25 Canada balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 26 Mexico balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 27 Europe balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 28 Germany balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 29 UK balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 30 France balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 31 Italy balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Spain balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Asia Pacific balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 34 Japan balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 35 China balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 36 India balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Australia balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Latin America balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Brazil balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 40 MEA balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 41 South Africa balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Saudi Arabia balloon valvuloplasty devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Market Participant Categorization
  • Fig. 44 Strategy mapping